Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020;21(5):629-30. Abstract
Coles CE et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol (R Coll Radiol) 2020;32(5):279-81. Abstract
Di Saverio S et al. Coronavirus pandemic and colorectal surgery: Practical advice based on the Italian experience. Colorectal Dis 2020;22(6):625-34. Abstract
Dietz JR et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020;181(3):487-97. Abstract
Gachabayov M et al. Considerations on colorectal cancer care in a COVID-19 pandemic epicenter. Surg Technol Int 2020;36:148-9. Abstract
Garassino MC et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): First results of an international, registry-based, cohort study. Lancet Oncol 2020;21(7):914-22. Abstract
Gillessen S, Powles T. Advice regarding systemic therapy in patients with urological cancers during the COVID-19 pandemic. Eur Urol 2020;77(6):667-8. Abstract
Horn L et al. Thoracic cancers international COVID-19 collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. ASCO 2020;Abstract LBA11.
Iavarone M et al. Management of hepatocellular carcinoma in the time of COVID-19. Ann Oncol 2020;31(8):1084-5. Abstract
Kuderer N et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 2020;395(10241):1907-18. Abstract
Luo J et al. COVID-19 in patients with lung cancer. Ann Oncol 2020;[Online ahead of print]. Abstract
Luo J et al. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov 2020;[Online ahead of print]. Abstract
Mehta AK, Smith TJ. Palliative care for patients with cancer in the COVID-19 era. JAMA Oncol 2020;[Online ahead of print]. Abstract
O'Shaughnessy J. Treatment options for patients with HR+/HER2- advanced breast cancer during the COVID-19 pandemic: Dose reduction of ribociclib does not diminish efficacy. Breast Cancer Res Treat 2020;182(1):243-4. Abstract
Pellino G, Spinelli A. How coronavirus disease 2019 outbreak is impacting colorectal cancer patients in Italy: A long shadow beyond infection. Dis Colon Rectum 2020;63(6):720-2. Abstract
Quarto G et al. Avoiding disruption of timely surgical management of genitourinary cancers during the early phase of COVID-19 pandemic. BJU Int 2020;[Online ahead of print]. Abstract
Robilotti EV et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med 2020;[Online ahead of print]. Abstract
Sehgal K et al. Extended-interval dosing strategy of immune checkpoint inhibitors in lung cancer: Will it outlast the COVID-19 pandemic? Front Onc 2020;10:1193. Abstract
Thoracic Surgery Outcomes Research Network, Inc. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Ann Thorac Surg 2020;110(2):692-6. Abstract
Wang T et al. Managing bladder cancer care during the COVID-19 pandemic using a team-based approach. J Clin Med 2020;22;9(5):1574. Abstract
Woul JW et al. Managing prostate cancer surgical patients during the COVID-19 pandemic: A brief report of the Duke Cancer Institute's initial experience. Oncology (Williston Park) 2020 13;34(5):156-62. Abstract
Yu J et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020;25;6(7):1108-10. Abstract
Zhao Z et al. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. Thorac Cancer 2020;11(6):1752-7. Abstract